Excitotoxic ablation

J Neurosurg. 2000 Aug;93(2):364-6. doi: 10.3171/jns.2000.93.2.0364.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / administration & dosage
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / therapeutic use*
  • Animals
  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / pharmacology
  • Antiparkinson Agents / therapeutic use*
  • Dopamine Agents / administration & dosage
  • Dopamine Agents / pharmacology
  • Dopamine Agents / therapeutic use*
  • Drug Delivery Systems
  • Globus Pallidus / drug effects*
  • Humans
  • Neurons / drug effects
  • Neurons / pathology
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / pathology
  • Parkinsonian Disorders / drug therapy*
  • Primates
  • Reproducibility of Results

Substances

  • Antiparkinson Agents
  • Dopamine Agents
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine